Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-26 Purchase | 2024-03-27 8:28 pm | Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer | 110,321 | $3.7263 | $411,094 | 570,814 (Indirect Direct) | View |
| 2023-12-12 Purchase | 2023-12-13 5:11 pm | Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer | 5,000 | $2.07 | $10,350 | 25,384,293 (Indirect Direct) | View |
| 2023-03-08 Purchase(A) | 2023-03-13 6:27 pm | Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-CEO & President | 23,527,044 | $1.05 | $24,703,396 | 9,884,095 (Indirect) | View |
| 2023-03-08 Purchase | 2023-03-08 9:31 pm | Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer | 23,527,044 | $1.05 | $24,703,396 | 33,279,364 (Indirect Direct) | View |
| 2022-08-16 Purchase | 2022-08-18 4:36 pm | Summit Therapeutics Inc. | SMMT | Zanganeh Maky Co-CEO & President | 5,809,132 | $0.97 | $5,634,858 | 3,495,435 (Indirect Direct) | View |
| 2021-05-12 Purchase | 2021-05-14 4:37 pm | Summit Therapeutics Inc. | SMMT | Zanganeh Maky Chief Operating Officer | 389,077 | $5.24 | $2,038,763 | 4,747,860 (Indirect) | View |
| 2020-06-23 Purchase | 2020-06-25 5:12 pm | Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director | 1,193 | $10.7 | $12,767 | 500,267 (Indirect Direct) | View |
| 2020-06-17 Purchase | 2020-06-19 4:22 pm | Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director | 7,950 | $7.01 | $55,730 | 499,074 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-03 Exercise | 2024-10-03 4:54 pm | 2020-06-24 2029-12-24 | Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer | 315,681 | $0 | 35,738,442 (Indirect) | View |
| 2024-10-03 Exercise | 2024-10-03 4:54 pm | N/A N/A | Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer | 315,681 | $1.58 | 35,738,442 (Indirect) | View |
| 2024-09-11 Option Award | 2024-09-13 7:29 pm | N/A N/A | Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-Chief Executive Officer | 44,052 | $22.7 | 35,422,761 (Indirect) | View |
| 2024-08-23 Option Award | 2024-08-23 4:42 pm | N/A 2032-06-28 | Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer | 2,757,640 | $0 | 2,757,640 (Direct) | View |
| 2024-08-09 Option Award | 2024-08-13 6:50 pm | N/A 2034-08-09 | PULSE BIOSCIENCES INC. | PLSE | Zanganeh Mahkam Director | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-07-03 Exercise | 2024-07-09 09:20 am | N/A N/A | PULSE BIOSCIENCES INC. | PLSE | Zanganeh Mahkam Director | 60,242 | $0 | 873,469 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-24 7:40 pm | N/A 2034-06-06 | Pulse Biosciences Inc. | PLSE | Zanganeh Mahkam Director | 28,247 | $0 | 28,247 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-13 5:11 pm | 2023-12-11 2025-06-30 | Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer | 805,495 | $0 | 25,384,293 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-13 5:11 pm | N/A N/A | Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer | 315,681 | $1.58 | 25,384,293 (Indirect) | View |
| 2023-12-11 Exercise | 2023-12-13 5:11 pm | N/A N/A | Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer | 489,814 | $1.44 | 25,384,293 (Direct) | View |
| 2023-11-13 Exercise | 2023-11-15 5:37 pm | N/A 2032-05-19 | Pulse Biosciences Inc. | PLSE | Zanganeh Mahkam Director | 76,075 | $0 | 752,985 (Direct) | View |
| 2023-11-13 Exercise | 2023-11-15 5:37 pm | N/A N/A | Pulse Biosciences Inc. | PLSE | Zanganeh Mahkam Director | 76,075 | $2.14 | 752,985 (Direct) | View |
| 2023-10-13 Option Award | 2023-10-16 4:08 pm | N/A 2033-10-13 | Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Chief Executive Officer | 11,988,198 | $0 | 11,988,198 (Direct) | View |
| 2023-06-09 Exercise(A) | 2023-07-06 8:30 pm | 2022-06-09 2027-06-09 | Pulse Biosciences Inc. | PLSE | Zanganeh Mahkam Director | 86,668 | $0 | 676,910 (Direct) | View |
| 2023-06-09 Exercise(A) | 2023-07-06 8:30 pm | N/A N/A | Pulse Biosciences Inc. | PLSE | Zanganeh Mahkam Director | 86,668 | $2.05 | 676,910 (Direct) | View |
| 2023-06-09 Exercise | 2023-06-13 5:26 pm | 2022-06-09 2027-06-09 | Pulse Biosciences Inc. | PLSE | Zanganeh Mahkam Director | 86,668 | $0 | 939,989 (Direct) | View |
| 2023-06-09 Exercise | 2023-06-13 5:26 pm | N/A N/A | Pulse Biosciences Inc. | PLSE | Zanganeh Mahkam Director | 86,668 | $2.05 | 939,989 (Direct) | View |
| 2023-05-25 Option Award | 2023-06-06 7:28 pm | N/A 2033-05-25 | Pulse Biosciences Inc. | PLSE | Zanganeh Mahkam Director | 40,168 | $0 | 40,168 (Direct) | View |
| 2022-12-06 Other | 2022-12-09 6:22 pm | N/A N/A | Summit Therapeutics Inc. | SMMT | Zanganeh Mahkam Co-CEO & President | 373,857 | $0 | 11,304,706 (Direct) | View |
| 2022-06-09 Exercise | 2022-06-10 6:59 pm | N/A N/A | Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director | 86,668 | $0 | 676,910 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-23 8:52 pm | N/A 2032-05-19 | Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director | 76,075 | $0 | 76,075 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 4:16 pm | N/A 2031-12-15 | Summit Therapeutics Inc. | SMMT | Zanganeh Maky Chief Operating Officer | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-21 5:09 pm | 2021-06-20 2031-05-20 | Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director | 28,026 | $0 | 28,026 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-21 4:32 pm | 2020-06-15 2025-06-15 | Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director | 3,307 | $0 | 503,574 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-21 4:32 pm | N/A N/A | Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director | 3,307 | $7.01 | 503,574 (Direct) | View |
| 2020-11-22 Option Award | 2020-11-24 6:12 pm | 2021-11-22 2030-11-22 | Summit Therapeutics Inc. | SMMT | Zanganeh Maky Chief Operating Officer | 2,400,000 | $0 | 8,083,282 (Direct) | View |
| 2020-11-11 Option Award | 2020-11-13 5:25 pm | 2021-11-11 2030-11-11 | Summit Therapeutics Inc. | SMMT | Zanganeh Maky Director | 203,323 | $0 | 7,004,460 (Direct) | View |
Ownership | 2020-11-13 5:20 pm | N/A N/A | Summit Therapeutics Inc. | SMMT | Zanganeh Maky Director | 0 | $0 | 5,479,960 (Indirect) | View |
| 2020-06-15 Exercise | 2020-06-17 4:09 pm | N/A N/A | Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director | 22,050 | $7.01 | 494,431 (Direct) | View |
| 2020-05-18 Option Award | 2020-05-19 6:26 pm | 2020-06-18 2030-05-18 | Pulse Biosciences Inc. | PLSE | Zanganeh Maky Director | 34,071 | $0 | 34,071 (Direct) | View |